High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease
Liver International · 2023
DOI: 10.1111/liv.15561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Aitor Odriozola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqué…. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Hypertension, Portal, Non-alcoholic Fatty Liver Disease, Elasticity Imaging Techniques. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Spleen stiffness measurement (SSM) by vibration‐controlled transient elastography (VCTE) has been tested in a limited number of studies versus hepatic venous pressure gradient (HVPG), especially with the 100 Hz spleen‐specific module. The current study aims to evaluate the diagnostic performance of this novel module for detecting clinically significant portal hypertension (CSPH) in a cohort of compensated patients with metabolic‐associated fatty liver disease (MAFLD) as the main aetiology and to improve the performance of the Baveno VII criteria for CSPH diagnosis by including SSM.
Methods
This is a retrospective single‐centre study including patients with available measurements of HVPG, Liver stiffness measurement (LSM) and SSM by VCTE with the 100 Hz module. Area under the receiver operating characteristic (AUROC) curve analysis was conducted to identify dual cut‐offs (rule‐out and rule‐in) associated with the absence/presence of CSPH. The diagnostic algorithms were adequate if negative predictive value (NPV) and positive predictive values (PPV) were >90%.
Results
A total of 85 patients were included, 60 MAFLD and 25 non‐MAFLD. SSM showed a good correlation with HVPG (MAFLD: r = .74; p < .0001; non‐MAFLD: r = .62; p < .0011). In MAFLD patients, SSM had a high accuracy in discarding/diagnosing CSPH (cut‐off values of 49.9 kPa, AUC 0.95). The addition of these cut‐offs in a sequential or combined approach to the Baveno VII criteria significantly reduced the grey zone (60% vs. 15%–20%), while maintaining adequate NPV and PPV.
Conclusions
Our findings support the utility of SSM for diagnosing CSPH in MAFLD patients and demonstrate that the addition of SSM to the Baveno VII criteria increases accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain.
- Statistical and Bioinformatic Unit, Valdecilla Research Institute (IDIVAL), Santander, Spain.
ORCID-Profile: Aitor Odriozola, Antonio Cuadrado, Paula Iruzubieta, María T Arias-Loste, Javier Crespo, José I Fortea
Zitieren
APA
Odriozola, A., Puente, Á., Cuadrado, A., Iruzubieta, P., Arias-Loste, M. T., Redondo, C., Rivas, C., Fábrega, E., Crespo, J., & Fortea, J. I. (2023). High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease. Liver International. https://doi.org/10.1111/liv.15561
Vancouver
Odriozola A, Puente Á, Cuadrado A, Iruzubieta P, Arias-Loste MT, Redondo C, et al. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease. Liver International. 2023. doi:10.1111/liv.15561
BibTeX
@article{Odriozola2023,
author = {Odriozola, Aitor and Puente, Ángela and Cuadrado, Antonio and Iruzubieta, Paula and Arias-Loste, María T and Redondo, Carlos and Rivas, Coral and Fábrega, Emilio and Crespo, Javier and Fortea, José I},
title = {High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15561}
}
EUVIMED